中文版 | English

在结果中检索

Arid

浏览/检索结果: 共3条，第1-3条 帮助

已选(0)清除 条数/页：   排序方式：
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study 期刊论文
发表期刊: LANCET RHEUMATOLOGY. 出版年: 2023, 卷号: 5, 期号: 9, 页码: E542-E552
作者:  Papp, Kim;  Warren, Richard B.;  Green, Lawrence;  Reich, Kristian;  Langley, Richard G.;  Paul, Carle;  Asahina, Akihiko;  Johnson, Lynne;  Arora, Vipin;  Osuntokun, Olawale;  Lebwohl, Mark
收藏  |  浏览/下载：8/0  |  提交时间：2024/09/29
Efficacy and safety of mirikizumab in psoriasis: results from a 52-week, double-blind, placebo-controlled, randomized withdrawal, phase III trial (OASIS-1) 期刊论文
发表期刊: BRITISH JOURNAL OF DERMATOLOGY. 出版年: 2022, 卷号: 187, 期号: 6, 页码: 866-877
作者:  Blauvelt, Andrew;  Kimball, Alexa B.;  Augustin, Matthias;  Okubo, Yukari;  Witte, Michael M.;  Capriles, Claudia Rodriguez;  Sontag, Angelina;  Arora, Vipin;  Osuntokun, Olawale;  Strober, Bruce
收藏  |  浏览/下载：7/0  |  提交时间：2024/09/20
Efficacy and safety of mirikizumab in psoriasis: 52-week results from the OASIS-1 randomized controlled trial 期刊论文
发表期刊: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 出版年: 2021, 卷号: 85, 期号: 3, 页码: AB64-AB64
作者:  Blauvelt, Andrew;  Kimball, Alexa B.;  Augustin, Matthias;  Okubo, Yukari;  Witte, Michael;  Sontag, Angelina;  Arora, Vipin;  Osuntokun, Olawale;  Strober, Bruce
收藏  |  浏览/下载：7/0  |  提交时间：2021/11/19